The EveryPrem Project
about the EveryPrem Project
The EveryPrem Project is evaluating a new, international tool INTER-NDA to measure neurodevelopment in 2 year-old children, who were born at less than 37 weeks of pregnancy, against the current developmental testing offered by the Neonatal Team at the John Radcliffe Hospital, Oxford to children. The purpose of the study is to assess the effectiveness, medium-term patient benefits and health care costs of this new neurodevelopmental test for all children, at 2 years of age, who were born preterm (at less than 37 weeks of pregnancy) at the John Radcliffe Hospital, Oxford, between April 2017 and April 2019.
Inter-NDA
The INTERGROWTH-21st Neurodevelopment assessment is a comprehensive and reliable tool to measure cognition, motor skills, language and behavior in 2-year old children.
Read moreEVERYPREM PROJECT
Read how the EveryPrem Project is evaluating the INTER-NDA for standardized neurodevelopmental screening at 2 years of age for all children born preterm.
RISKS, BENEFITS & FAQs
Read about the possible benefits, disadvantages and risks of taking part, our commitment to confidentiality, expenses, what happens to the results and more.
HEALTH PROFESSIONALS
For General Practitioners, please see more information about the study here. For access to the full research proposal, please click here.
CONTACT
For further information about the study, please contact:
The EveryPrem Project ouh-tr.everyprem@nhs.net or Josephine Agyeman-Duah josephine.agyeman-duah@wrh.ox.ac.uk.
For concerns or complaints, please contact stephen.kennedy@wrh.ox.ac.uk the Chief Investigator.
RECRUITMENT REPLY
(ELIGIBLE PARENTS ONLY)
-
Josephine Agyeman-Duah
DPhil Student & Student Committee Vice President
-
Michelle Fernandes
Clinical Lecturer, MRC Clinical Research Training Fellow
